TAMPA BAY, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Energetic Harmony ℠, a leader in holistic stress relief, proudly ...

Importance des vétérinaires : les vétérinaires restent la source d’information la plus fiable pour les propriétaires d’animaux de compagnie, la majorité des Canadiens interrogés reconnaissant leur ...

Value of Veterinarians: Veterinarians continue to be the most trusted source of information about pet health for pet owners, with the majority of Canadians surveyed valuing their expertise, ...

The new add-on aims to streamline laboratory labeling by combining the Dymo® LabelWriter™5-Series (550, 550 Turbo, and 5XL) ...

This investment is pending the closing of the merger between SRx Health Solutions and Better Choice Company, which is scheduled for late-April. Upon closing, the combined companies will emerge as a ...

This investment is pending the closing of the merger between SRx Health Solutions and Better Choice Company, which is scheduled for late-April. Upon closing, the combined companies will emerge as a ...

Each Unit consisted of (i) one common share in the capital of the Company (each, a “ Common Share ”), and (ii) one Common Share purchase warrant (each, a “ Warrant ”). Each Warrant entitles the holder ...

All of the shares of common stock to be sold in the offering will be sold by the Company. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 2,400,000 ...

The TRX103 Phase 1/2a clinical trial is being led by Maria Grazia Roncarolo, MD, co-founder, president and head of R&D at Tr1X, with patients enrolling at leading stem cell transplant centers across ...

Radforsk Investeringsstiftelse, a close associate of Anders Tuv, Chair of the board of directors and primary insider of the Company, has today transferred 1730 existing shares in the Company to DNB ...

Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin ...

Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. (“POI”) dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 ...